Table 1.
The demographic and clinical features of the patients
| Variable | Group P (n = 32) | Group R (n = 32) | P value |
|---|---|---|---|
| Age (yr) | 66.1 ± 9.4 | 64.7 ± 8.3 | 0.537 |
| Gender (men/women) | 5 (15.6)/ 27 (84.4) | 7 (21.9)/ 25 (78.1) | 0.750 |
| BMI (kg/m2) | 30.9 ± 3.7 | 31.0 ± 3.2 | 0.928 |
| Side of treatment (left/right) | 20 (62.5)/ 12 (37.5) | 12 (37.5)/ 20 (62.5) | 0.079 |
| Duration of pain (mo) | 15.4 ± 2.2 | 14.8 ± 2.2 | 0.333 |
| KL grade (3/4) | 20 (62.5)/ 12 (37.5) | 22 (68.7)/ 10 (31.3) | 0.792 |
| DM | 5 (15.6) | 4 (12.5) | > 0.999 |
Values are presented as mean ± standard deviation or number (%).
Group P: phenol neurolysis group, Group R: radiofrequency ablation group, BMI: body mass index, KL: Kellgren–Lawrence, DM: diabetes mellitus.